tiprankstipranks

Hans van Houte Insider Profile

4 Followers
Hans van Houte, CFO at Nurix Therapeutics, holds 33.72K shares in Nurix Therapeutics (Ticker: NRIX).
tipranks
Hans van Houte

Hans van Houte
Nurix Therapeutics (NRIX)
CFO

Not Ranked
Hans van Houte has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$467K
100.00%
A breakdown of Hans van Houte's holdings

Insider Roles

Nurix Therapeutics
(NRIX)
CFO
Roles that Hans van Houte holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Hans van Houte

Hans van Houte's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Nurix Therapeutics
Mar 03, 2025
CFO
Uninformative Sell
84.33K
$467.41K
Hans van Houte has not reported any informative transactions for NRIX, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Feb 23, 2021
Uninformative Buy
$5.89K
-
$1.10
Feb 25, 2021
Uninformative Buy
$62.30K
-
$1.75
Feb 22, 2021
Uninformative Buy
$11.41K
-
$0.84
May 03, 2022
Uninformative Buy
$24.23K
-
$11.20
Jun 01, 2022
Uninformative Buy
$57.40K
-
$0.84
List of latest transactions for each holding click on a transaction to see Hans van Houte's performance on stock

Hans van Houte insider profile FAQ

What is the percentage of profitable transactions made by Hans van Houte?
The percentage of profitable transactions made by Hans van Houte is ―.
    What is the average return per transaction made by Hans van Houte?
    The average return per transaction made by Hans van Houte is ―.
      What stocks does Hans van Houte hold?
      Hans van Houte holds: NRIX stocks.
        What was Hans van Houte’s latest transaction?
        Hans van Houte latest transaction was an Uninformative Sell of $84.33K.
          What was Hans van Houte's most profitable transaction?
          Hans van Houte’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Hans van Houte's role in Nurix Therapeutics?
            Hans van Houte's role in Nurix Therapeutics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.